Anti-aging Medicine Solutions
Jointechlabs Inc. is an emerging leader in point-of-care regenerative and rejuvenation medicine therapies. We have patented, portable medicine products that enable personalized therapies. FDA cleared – MiniTC™ CE Mark pending – Mini-Stem System™
FDA cleared, disposable, hand-held medical device for isolation of fragmented and purified fat grafts (microfat) at the point-of-care.
CE Mark pending, disposable, portable medical device for isolation of adipose tissue derived stromal vascular fraction (SVF) at the point-of-care.
Adipose tissue derived stem cell therapeutic product for Osteoarthritis.
MiniTC™ is an FDA-cleared portable medical device for isolation of fragmented and purified fat grafts (microfat) at the point-of-care. It is a patented, disposable, closed loop medical device that can be used for processing of lipoaspirate (fat) in any clinic setting, with no change in infrastructure. The end-product is finely washed injectable microfat which can be used for autologous implant alone or in conjunction with biocompatible carriers. The device can be used in a broad range of therapeutic areas, such as medical aesthetics, plastic and reconstructive surgeries, orthopedics and wound care.
FDA cleared, patented, disposable, closed loop medical device that can be used in various clinical settings
Enables point-of-care fat tissue processing to isolate fragmented and purified fat grafts (microfat)
No capital costs
Half the cost compared to leading competitors in the US and Europe
Easy to use and less cumbersome
Can also be used as a platform for combination therapies and clinical research
Microfat is your own processed and fragmented fat, which is rich in regenerative cells. Microfat preserves the integrity of fat tissue and the stromal (stem) cells within its natural niche which helps in the reconstruction, rejuvenation and healing of tissues. Microfat can then be applied or injected to areas of injury, inflammation or for aesthetic contouring.
Mini-Stem System™ system is a CE-mark pending medical device for isolation of fat-derived stromal vascular fraction (SVF) at the point-of-care. It is a patented, disposable, closed loop medical device that can be used for processing of lipoaspirate (fat) in any clinic setting, with no change in infrastructure. The end-product is an injectable stem cell fraction (SVF) which can be used for autologous therapy alone or in conjunction with biocompatible carriers. The device can be used in a broad range of therapeutic areas, such as medical aesthetics, plastic & reconstructive surgeries, orthopedics and wound care.
CE-mark pending, patented, disposable, closed loop medical device that can be used in various clinical settings
Enables point-of-care fat tissue processing to stem cell fraction (SVF).
No major capital costs
Half the price to leading competitors
SVF is a cellular product rich in your own fat-derived stem cells that have been shown to possess powerful anti-inflammatory and immunomodulatory functions. SVF, when injected, helps in the reconstruction, regeneration and healing of tissues.
Based on our platform and technology, Jointechlabs is developing therapies for unmet medical needs. Our first therapeutic in clinical development JTL-T-01 is a proprietary injectable stem cell scaffold as a biologic therapy for osteoarthritis, for approval under the FDA’s fast-track program. JTL-T-01 has been designed as an autologous point-of-care therapy enabling the patient’s own stem cells to be locally injected into the affected joints. A portion of the pre-clinical study for JTL-T-01 is funded by the National Institutes of Health’s small business grant in collaboration with Rush University, Chicago.
MiniTC™ (USA) and Mini-Stem System™ (EU and other countries) have applications in medical aesthetics, plastic and reconstructive surgery, orthopedics and wound healing among others.
Restores fullness and shape; adds volume; decreases skin sag; erases stretch marks.
Rejuvenation of face; improves skin texture, wrinkles, fine lines and acne scars; adds volume.
Improves blood circulation to chronic wounds; decreases inflammation and pain; promotes faster healing and regeneration
Reduces pain; decreases inflammation; helps repair cartilage and soft tissue injuries; improves healing and prompts return to active lifestyle.
MiniTC™ offers a simplified protocol of just two centrifugation steps for obtaining injectable microfat in about 20 minutes. Step one eliminates the blood and anesthetic contaminants, and step two allows breaking of dense fat into microfat where regenerative cells are preserved. Injectable microfat is then collected by connecting the syringe to the luer on top of the device. (Please follow the Instructions for use when using MiniTC™).
Mini-Stem System™ replicates the multi-step laboratory process of isolating stromal vascular fraction (SVF) from fat, but within the portable device in a closed-loop by introducing and collecting the materials through particular luer ports on the device. The main steps of the Mini-Stem System protocol, which are tissue washing, tissue enzymatic digestion and filtration of the digested fraction, are executed within the device itself. (Please follow the instructions for use when using Mini-Stem System™)
JTL-T-01 Therapy is a pipeline therapeutic product under clinical development which combines a unique method of stromal vascular fraction (SVF) extraction from fat and its embedment into injectable scaffold. JTL-T-01 has been designed as an autologous point-of-care therapy for osteoarthritis useful for mitigation of pain, inflammation and cartilage deterioration.
Multipurpose digital centrifuge recommended for MiniTC™ and Mini-Stem System™ protocols. It can run 99 other programs as needed.
Multipurpose digital temperature-controlled shaker recommended for Mini-Stem System™ protocol.
Convenient sterile, cost effective kit for minimally-invasive liposuction at the point-of-care.
Jointechlabs designed its innovative devices to harness the natural healing powers of the body. We continue to pioneer innovation by using the MiniTC™ and Mini-Stem System™ devices as platform to develop novel products.
Tissue 3D printing
We are working on tissue 3D printing based on a combination of our devices with existing portable 3D bioprinting device, and proprietary scaffold hydrogels which will provide unique opportunity for development of breakthrough therapies for unmet medical needs. The platform and the method of embedment of the cellular product into injectable and printable biologic product are protected by broad portfolio of issued patents, pending patents and PCTs.
Therapy Development through partnerships
Using our devices as a platform, we are developing therapies with biotech/government partners for different clinical indications as below;
Nathan is an inventor, and entrepreneur with 30 years of experience in the fields of stem cells, medical device, and human genetics. His record includes peer-reviewed publications and scientific presentations. He led the company to its first FDA clearance, massive IP portfolio, NIH grant awards, and efficient R & D and manufacturing. Nathan has built a management team of dedicated professionals and established collaborations with most prominent experts in the regenerative medicine field.
Nishit is an entrepreneurial leader with 15+ years of experience in regenerative medicine, and strong knowledge of business operations. His approach based on scientific rationale, and commercial opportunity is pivotal in the company’s regulatory approval strategies across clinical indications, and geographies. Nishit leads development and execution utilizing available resources to meet ongoing business needs while managing relationships with advisors, vendors, and key stake holders.
Thom has over 30 years of experience in regulatory affairs, in both start-up and Fortune 500 companies. He has written and coordinated over 50 regulatory filings for commercialization of medical devices in 27 countries, including authoring over thirty-five 510(k) submissions.
A seasoned public relations specialist, Betsy has an exceptional track record of managing communications for healthcare companies. Stemming from her years on agency side, in-house role at Genentech and as a consultant to startups, Betsy provides clients with strategic advisory for announcement of key milestones, thought leadership development and reputation management.
Attorney Steven Ivy is a member of the Illinois Bar, and a member of the Bar of the USPTO. His combined 28 years of programming, engineering, management, business ownership, financial planning, and legal experience, makes him one of the most uniquely qualified business attorneys in the country.
Mr. Penn is a Partner with the law firm, Lempia Summerfield Katz LLC and has over 25 years of experience assisting companies in managing their intellectual property rights. Mr. Penn is licensed as a patent attorney and represents Jointechlabs Inc. before the US Patent Office, has extensive patent prosecution experience regarding medical and life sciences inventions, and focuses on obtaining patents that align with business strategy.
Karl focuses his practice in FDA Regulatory law, representing U.S. and international clients in the food
and drug industries for pharmaceuticals and OTC drugs, biologics, medical devices. He has vast
experience in the areas of regenerative medicine and has counseled numerous clients seeking FDA approval for cellular-based products to treat both humans and animals.
Jointechlabs has the best product at the best price in the autologous regenerative
medicine fi eld. I know all of these products. I will use them as a vendor, I am a
physician. My interest is in helping patients, not generating revenue from an
investment. The management team is also highly qualified, experienced and
I appreciate the scientific honesty of the team. All their work is based on scientific
evidence and objective results. I find it really important that they share their
research with other colleagues and that they are open to accepting suggestions
and ideas from other colleagues. This makes the difference between teams that
work only for economic results versus those that care about scientific research.
Great system!!! Very versatile, awesome hands too!! So likely great outcome!!
Good product, good price, good combination
MiniTC™ is a disposable, closed loop medical device that can be used in the clinic setting, with no change in infrastructure, eliminating the need for manual processing of fat tissue. Also, the device is less costly, cumbersome and labor intensive compared to what currently exists.
Yes, with MiniTC™, manual processing of fat tissue in the lab is eliminated, thus making it more standardized and applicable in clinic settings.
MiniTC™ is intended for use in the following specialties when the transfer of harvested adipose tissue is desired: orthopedics, arthroscopic surgery, plastic and reconstructive surgery (when aesthetic body contouring is desired), neurosurgery, gastrointestinal and affiliated organ surgery, urological surgery, general surgery, gynecological surgery, thoracic surgery and laparoscopic surgery.
For the use of MiniTC™, Jointechlabs plans to focus on reaching healthcare practitioners and physicians in a variety of specialties, including medical aesthetics, plastic and reconstructive surgery, orthopedics, internal medicine (e.g., primary care physicians who handle aesthetics or orthopedic procedures) and wound healing.
MiniTC™ can be purchased from authorized distributors in your territory. A list of distributors is available on the website . If your territory is not currently assigned to a distributor, you can purchase MiniTC directly from Jointechlabs by reaching us via our contact page
There are several ways to receive training of MiniTC™. In some cases training can be arranged in-person. Otherwise, Jointechlabs offers an online webinar in addition to ‘how-to-use’ training and 3D animation videos, along with instructions-for-use details, available on the website.
Jointechlabs Launches MiniTC for Point-of-Care Fat Tissue Processing The scientific community has regarded regeneration as a topic of interest for thousands of years.
Jointechlabs – a leader in point-of-care regenerative medicine therapies – today announced that the U.S. Food and Drug Administration (FDA) cleared the […]
Nathan Katz, MSc, PhD, Jointechlabs, Inc., USA Avner Yayun, MD, PhD, Procore Biomed, Israel Procore Biomed has developed a hyaluronic-acid – plasma cross-linked hydrogel “RegenoGel” ..
108 South Wynstone Park drive, Suite 114, North Barrington IL 60010